there appears to be a well-substantiated benefit equivalent to that of sulfasalazine achieved by the new oral formulations of 5-asa when used for the treatment of acute mild to moderate ulcerative colitis , and as maintenance treatment of ulcerative colitis in remission .
C0036078
sulfasalazine
C0009324
ulcerative colitis